LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults
LATE-COVID
Complications Post COVID-19 - Observational Study in Children and Adults
1 other identifier
observational
500
1 country
1
Brief Summary
All consecutive patients admitted to the Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland between 1st October 2020 and 31st December 2021 due to symptoms, which might reflect complications following COVID-19, will be included in the observational cohort study. Data concerning clinical characteristics, results of laboratory tests, other studies, such as: echocardiography, 24 hours ambulatory ECG recording will be collected. The study is planned also to be extended with the genetic predisposition in children to COVID-19 late complications (within independent grant).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 14, 2021
CompletedFirst Posted
Study publicly available on registry
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMarch 16, 2021
March 1, 2021
1.7 years
March 14, 2021
March 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of participants with severe post-COVID-19 complications
Data concerning clinical characteristics, results of laboratory tests, other studies, such as: echocardiography, 24 hours ambulatory ECG recording will be collected. According to the results patients will be qualified to severe or mild complication group
Baseline
Factors related to the severity of post-COVID-19 complications
Data concerning clinical characteristics, results of laboratory tests, other studies, such as: echocardiography, 24 hours ambulatory ECG recording will be collected to verify which of them can be related to the severity of post-COVID-19 complications.
Baseline
Other Outcomes (1)
Post-COVID SCORE
Baseline
Study Arms (2)
Adult patients with complications post COVID-19
Children with complications post COVID-19
Eligibility Criteria
All consecutive COVID-19 convalescents admitted to the Departments of Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland, for complications
You may qualify if:
- consecutive COVID-19 convalescents (the infection of coronavirus was confirmed with real-time polymerase chain reaction test or positive result of autoantibodies) admitted to the Departments of Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland, for complications
You may not qualify if:
- no history of COVID-19 infection,
- lack of complications post COVID-19,
- severe course of Sars-COV-2 infection,
- lack pf patient's agreement to be included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland
Lodz, 93-338, Poland
Related Publications (5)
Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis. 2021 Jul-Aug;67:53-64. doi: 10.1016/j.pcad.2021.02.008. Epub 2021 Feb 20.
PMID: 33621589BACKGROUNDPetrovic V, Radenkovic D, Radenkovic G, Djordjevic V, Banach M. Pathophysiology of Cardiovascular Complications in COVID-19. Front Physiol. 2020 Oct 9;11:575600. doi: 10.3389/fphys.2020.575600. eCollection 2020.
PMID: 33162899BACKGROUNDBhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020 Jul 10;11:1648. doi: 10.3389/fimmu.2020.01648. eCollection 2020.
PMID: 32754159BACKGROUNDRadenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M. Cholesterol in Relation to COVID-19: Should We Care about It? J Clin Med. 2020 Jun 18;9(6):1909. doi: 10.3390/jcm9061909.
PMID: 32570882BACKGROUNDLewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study. Arch Med Sci. 2021 Mar 18;17(3):818-822. doi: 10.5114/aoms/134211. eCollection 2021.
PMID: 34025853RESULT
Biospecimen
The study is planned also to be extended with the genetic predisposition in children to COVID-19 late complications (within independent grant).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,PhD,FNLA,FAHA,FESC,FASA
Study Record Dates
First Submitted
March 14, 2021
First Posted
March 16, 2021
Study Start
October 1, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
March 16, 2021
Record last verified: 2021-03